The "2024-2030 China Third-party Medical Testing and Diagnosis Industry Market Operation Situation and Development Prospect Research and Judgment Report" (hereinafter referred to as the "Report") created by the expert team of Zhiyan Consulting was officially announced, and since its publication in 2019, it has been selling well for 6 consecutive years, and has successfully become a powerful reference material for enterprises to understand and develop the market and formulate strategic directions. From the macro strategic perspective of national economic and industrial development, the report deeply analyzes the future market trends of the third-party medical testing and diagnosis industry, accurately excavates the development potential of the industry, and judges the future prospects of the third-party medical testing and diagnosis industry.
This report is divided into 10 chapters, including development overview, operating environment, industry status, competitive landscape, key manufacturers, development strategies, and industry trends. It involves core data such as the number of third-party medical testing and diagnosis institutions and the market size.
All the data in the report are obtained from public information such as official institutions, industry associations and in-depth research, and the data has been verified in detail and verified by multiple parties, in order to provide accurate, reliable and effective value information for the industry!
Third-party medical testing (diagnosis) refers to the medical diagnostic testing services provided for hospitals, community health service centers, township health centers, physical examination centers, disease control centers, etc., independent of medical institutions, usually including blood testing, genetic testing, pathological diagnosis, imaging diagnosis and other services. Third-party medical diagnosis enterprises are divided into two categories: comprehensive independent medical laboratories and professional independent medical laboratories, which can be divided into two categories: chain type and non-chain type.
With the improvement of people's living standards and the acceleration of population aging, the continuous growth of medical care demand, and the continuous development and popularization of new technologies have brought new opportunities for the industry. In 2022, the market size of the third-party medical testing and diagnosis industry in mainland China will reach 66.232 billion yuan, and with the continuous advancement of the reform of the medical and health system, in order to ensure the high-quality development of the health industry, the state will continue to improve the governance system, improve the supervision capacity of the medical insurance fund, and further standardize the supply of medical and health services. Subsequently, in August, a one-year centralized rectification of corruption in the national pharmaceutical field was launched, and the problem-oriented system governance of the whole field, the whole chain and the full coverage of the pharmaceutical industry was carried out in depth. In December, the National Health Commission issued the "Notice on the Inspection Work Plan for Large Hospitals (2023-2026)", and the centralized rectification of corruption in the pharmaceutical field is still the focus of inspections in the next three years, and the implementation of this series of regulatory policies will promote the development of the third-party medical inspection industry in the direction of compliance, health and sustainability, and the market size of the third-party medical testing and diagnosis industry in mainland China will drop to 44.936 billion yuan in 2023, and the industry will enter a period of standardized development.
The upstream industry of the third-party medical testing and diagnosis industry mainly includes medical devices, diagnostic reagents, consumables and other industries, and the downstream of the industry is an institution that provides medical services for patients. In recent years, the improvement of people's living standards and the acceleration of population aging, the continuous growth of medical care demand, driving the rapid growth of third-party medical testing and diagnosis market demand, at the same time, with the continuous deepening of the reform of the medical and health system in mainland China, the further strengthening of supervision, the development of the industry is also facing new opportunities and challenges.
At present, the competition pattern of the third-party medical testing and diagnosis industry in mainland China has been initially formed, showing a situation dominated by large-scale comprehensive institutions and diversified professional institutions competing for development. Service optimization, brand building, improve detection accuracy and efficiency to maintain market competitiveness.
As a professional organization that has witnessed the development of third-party medical testing and diagnosis in China for more than ten years, Zhiyan Consulting hopes to work together with all enterprises committed to third-party medical testing and diagnosis industry to provide more effective information, professional consulting and personalized customized industry solutions, and make a modest contribution to the development of the industry.
Data Description:
1: The core data of this report has been updated to December 2023 (the relevant financial indicators of non-listed companies in the report are affected by corporate credit approval, and there may be a certain lag), and the forecast period of the report is 2024-2030.
2: In addition to the first-hand research information and data, authoritative data sources such as the National Bureau of Statistics, China Customs, industry associations, and public reports of listed companies (prospectuses, transfer prospectuses, annual reports, inquiry reports, etc.) also constitute the data sources of this report. The first-hand data comes from the first-hand information data obtained by the research team from interviews with key enterprises in the industry, and the main interview subjects include corporate executives, industry experts, technical leaders, downstream customers, distributors, agents, distributors and upstream raw material suppliers. Secondary sources mainly include relevant industry news, company annual reports, non-profit organizations, industry associations, government agencies and third-party databases from around the world.
3: The core data of the report is based on the strict data collection, screening, processing, analysis system and independent calculation model of the Zhiyan team to ensure the accuracy and reliability of statistical data.
4: The data used in this report are all from compliance channels, and the analysis logic is based on the professional understanding of the Zhiyan team, which clearly and accurately reflects the research views of analysts.
As a leading brand in the field of industrial consulting in China, Zhiyan Consulting takes "driving industrial development with information and empowering enterprise investment decision-making" as its brand concept. The company integrates quantitative analysis and qualitative analysis methods, uses self-developed algorithms, combines industry cross-big data, and excavates the root causes behind quantitative data through diversified analysis, analyzes the logic behind qualitative content, objectively and truthfully explains the current situation of the industry, prudently predicts the future development trend of the industry, and provides customers with professional industry analysis, market research, data insights, strategic consulting and related solutions to help customers improve their cognitive level, profitability and comprehensive competitiveness. The main services include high-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, industrial planning, etc. Provide weekly/monthly/quarterly/annual reports and other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.